PGIM Nasdaq-100 Buffer 12 ETF – April (NASDAQ:PQAP – Get Free Report) saw a large increase in short interest in the month of October. As of October 15th, there was short interest totaling 17,332 shares, an increase of 86,560.0% from the September 30th total of 20 shares. Based on an average daily volume of 3,602 shares, the days-to-cover ratio is presently 4.8 days. Currently, 1.8% of the shares of the company are sold short.
Hedge Funds Weigh In On PGIM Nasdaq-100 Buffer 12 ETF – April
An institutional investor recently bought a new position in PGIM Nasdaq-100 Buffer 12 ETF – April stock. Citadel Advisors LLC purchased a new stake in shares of PGIM Nasdaq-100 Buffer 12 ETF – April (NASDAQ:PQAP – Free Report) during the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 7,464 shares of the company’s stock, valued at approximately $239,000. Citadel Advisors LLC owned 0.90% of PGIM Nasdaq-100 Buffer 12 ETF – April as of its most recent SEC filing.
PGIM Nasdaq-100 Buffer 12 ETF – April Stock Up 0.5%
NASDAQ:PQAP traded up $0.16 during mid-day trading on Monday, hitting $32.87. 147 shares of the company traded hands, compared to its average volume of 5,583. The stock’s fifty day moving average price is $32.79 and its 200-day moving average price is $32.05. The firm has a market cap of $31.88 million, a price-to-earnings ratio of 30.53 and a beta of 0.43. PGIM Nasdaq-100 Buffer 12 ETF – April has a one year low of $27.83 and a one year high of $33.27.
About PGIM Nasdaq-100 Buffer 12 ETF – April
The PGIM Nasdaq-100 Buffer 12 ETF – April (PQAP) is an exchange-traded fund that mostly invests in large cap equity. The fund aims for specific buffered losses and capped gains on the Invesco QQQ Trust over a specific holdings period. The actively managed fund holds FLEX options. PQAP was launched on Dec 27, 2024 and is issued by PGIM.
Recommended Stories
- Five stocks we like better than PGIM Nasdaq-100 Buffer 12 ETF – April
- Comfort Systems Earnings: AI Slowdown or More Growth Ahead?
- Bristol Myers Squibb’s Cancer Breakthrough Could Have Implications Beyond Its Own Stock
- 5 Beaten-Down Growth Stocks Trading Like Value Plays as Cash Chases Mega-Caps
- Anthropic’s IPO Filing Reveals a Massive Opportunity for AI Infrastructure Giants
Receive News & Ratings for PGIM Nasdaq-100 Buffer 12 ETF - April Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PGIM Nasdaq-100 Buffer 12 ETF - April and related companies with MarketBeat.com's FREE daily email newsletter.
